Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| New York Genome Center | RCV002227586 | SCV002506621 | likely pathogenic | Dyskeratosis congenita, autosomal recessive 5 | 2021-05-21 | criteria provided, single submitter | clinical testing | The inherited c.3578delT variant in exon 34 of 35 of RTEL1 is predicted to result in frameshift and subsequent termination after 170 amino acid residues (p.Val1193GlyfsTer171). This frameshift is predicted to alter the amino acid sequence in the C-terminal region of RTEL1 which contains the conserved ring finger domain [1217-1300 aa; 3]. Two missense variants in this domain have been reported in multiple affected individuals [PMID: 28507545; PMID: 25047097; PMID: 23453664; PMID: 25099625; PMID: 26025130; PMID: 24009516; PMID: 25620558]. This suggests that these amino acid residues are important for the function of RTEL1, and variants that disrupt this region are likely to be disease-causing. The variant seen has not been reported in affected individuals in the available literature and is absent in gnomAD v3 indicating it is not a common benign variant in the populations represented in this database. This variant is not reported in Clinvar and there are at least 3 frameshift variants downstream to the one seen in this individual that are reported as Pathogenic/Likely pathogenic (Variation IDs: 656263,10683954) or seen in an affected individual [PMID: 28507545]. Given the current evidence, the c.3578delT (p.Val1193GlyfsTer171) variant identified in the RTEL1 gene is reported as a Likely Pathogenic. |